Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.66 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.61 |
| ▸ | TP53 | P04637 | 3/20 | 0.61 |
| ▸ | TSHR | P16473 | 3/20 | 0.61 |
| ▸ | MAPT | P10636 | 2/20 | 0.61 |
| ▸ | HPGD | P15428 | 2/20 | 0.61 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.61 |
| ▸ | MEN1 | O00255 | 2/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.61 |
| ▸ | PKM | P14618 | 2/20 | 0.61 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.61 |
| ▸ | PPARG | P37231 | 1/20 | 0.61 |
| ▸ | LMNA | P02545 | 1/20 | 0.61 |
| ▸ | GAA | P10253 | 1/20 | 0.61 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.58 |
| ▸ | GLA | P06280 | 1/20 | 0.46 |
| ▸ | APP | P05067 | 7/20 | 0.45 |
| ▸ | FGFR1 | P11362 | 1/20 | 0.41 |
| ▸ | SRC | P12931 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7965385 | 1.00 | TDP1 (0.66) | TDP1ALDH1A1TP53TSHRMAPT | |
| SCHEMBL7965384 | 1.00 | TDP1 (0.66) | TDP1ALDH1A1TP53TSHRMAPT | |
| SCHEMBL11745698 | 0.94 | TDP1 (0.59) | TDP1ALDH1A1TP53TSHRMAPT | |
| SCHEMBL20677146 | 0.89 | TDP1 (0.79) | TDP1ALDH1A1TP53TSHRMAPT | |
| SCHEMBL21094081 | 0.89 | TDP1 (0.79) | TDP1ALDH1A1TP53TSHRMAPT | |
| SCHEMBL50264 | 0.89 | TDP1 (0.79) | TDP1ALDH1A1TP53TSHRMAPT | |
| SCHEMBL16392443 | 0.84 | TDP1 (0.66) | TDP1ALDH1A1TP53TSHRMAPT | |
| SCHEMBL14088749 | 0.83 | TDP1 (0.70) | TDP1ALDH1A1TP53TSHRMAPT | |
| SCHEMBL21202704 | 0.83 | TDP1 (0.70) | TDP1ALDH1A1TP53TSHRMAPT | |
| SCHEMBL2720991 | 0.83 | TDP1 (0.70) | TDP1ALDH1A1TP53TSHRMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122037009-A | Solid catalyst component, catalyst for olefin prepolymerization or polymerization, and method for olefin prepolymerization or polymerization | 中国石油化工股份有限公司 | 2026-05-15 | — | — | CN | disclosed |
| CN-122037005-A | Catalytic composition, catalyst for olefin prepolymerization or polymerization, process for olefin prepolymerization or polymerization | 中国石油化工股份有限公司 | 2026-05-15 | — | — | CN | disclosed |
| CN-122037013-A | Catalytic component, catalyst for olefin prepolymerization or polymerization, and method for olefin prepolymerization or polymerization | 中国石油化工股份有限公司 | 2026-05-15 | — | — | CN | disclosed |
| CN-122037006-A | Catalyst component for olefin polymerization, catalyst for olefin prepolymerization or polymerization, and method for olefin prepolymerization or polymerization | 中国石油化工股份有限公司 | 2026-05-15 | — | — | CN | disclosed |
| EP-3191453-B1 | PHENYL-(AZA)CYCLOALKYL CARBOXYLIC ACID GPR120 MODULATORS | BRISTOL MYERS SQUIBB CO (US) | 2019-10-23 | — | — | EP | disclosed |
| US-9506003-B2 | Lubricants for magnetic recording media | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2016-11-29 | — | — | US | disclosed |
| EP-2459570-B1 | NITROIMIDAZOOXAZINE ANALOGUES AND THEIR USES | GLOBAL ALLIANCE FOR TB DRUG DEV (US) | 2014-12-24 | — | — | EP | disclosed |
| US-8293734-B2 | Nitroimidazooxazine and nitroimidazooxazole analogues and their uses | GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT (US) | 2012-10-23 | — | — | US | disclosed |
| EP-2459570-A1 | NITROIMIDAZOOXAZINE AND NITROIMIDAZOOXAZOLE ANALOGUES AND THEIR USES | Global Alliance For Tb Drug Development (US) | 2012-06-06 | — | — | EP | disclosed |
| WO-2011014776-A1 | NITROIMIDAZOOXAZINE AND NITROIMIDAZOOXAZOLE ANALOGUES AND THEIR USES | GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT (US) | 2011-02-03 | — | — | WO | disclosed |
| US-20110028466-A1 | NITROIMIDAZOOXAZINE AND NITROIMIDAZOOXAZOLE ANALOGUES AND THEIR USES | GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT (US) | 2011-02-03 | — | — | US | disclosed |
| CN-1315830-A | Method for treating anxiety disorders | LILLY CO ELI (US) | 2001-10-03 | — | — | CN | disclosed |
| US-6242450-B1 | SUBSTITUTED PIPERIDINES | ELI LILLY AND COMPANY | 2001-06-05 | — | — | US | disclosed |
| WO-2000006082-A2 | TREATMENT OF ANXIETY DISORDERS | ELI LILLY AND COMPANY (US) | 2000-02-10 | — | — | WO | disclosed |
| WO-2000006166-A1 | 5-HT1F ANTAGONISTS | ELI LILLY AND COMPANY (US) | 2000-02-10 | — | — | WO | disclosed |
| EP-0976746-A1 | 5-HT1F antagonists | ELI LILLY AND COMPANY (US) | 2000-02-02 | — | — | EP | disclosed |
| EP-0976747-A2 | Use of 5HT-1F receptor antagonists for treating anxiety disorders | ELI LILLY AND COMPANY (US) | 2000-02-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110028466-A1 | NITROIMIDAZOOXAZINE AND NITROIMIDAZOOXAZOLE ANALOGUES AND THEIR USES | NOX5, NQO2, SIRT5 | TDP1 1952/4885ALDH1A1 2444/4885TP53 2865/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.